Due diligence in aesthetic medicine area

Ethica Global Investments has announced its recent entry into the aesthetic medicine sector through the acquisition of a minority stake in Regenyal and Phitogen Beauty Labs. Both companies, which are under RP Group control, are specialized in the manufacture of hyaluronic acid products.

By supporting the growth of both companies in international markets, Ethica Global Investments aims to strengthen their presence in the increasingly expanding aesthetic medicine sector and help develop new technologies and cutting-edge products.

To conclude this transaction, Ethica Global Investments has entrusted Proj.Eco Engineering with a due diligence regarding safety, environment and machine compliance.

Read more here:

Press